[1]
Zhang, X. et al. 2025. BTK Inhibitor Downregulates IL-17 Secretion and Enhances CD20mb Sensitivity to ABC Type Diffuse Large B-cell Lymphoma via CYLD/NF-kB Signaling Pathway. International Journal of Biology and Life Sciences. 11, 2 (Aug. 2025), 10–23. DOI:https://doi.org/10.54097/x2wh3a34.